Old and New World arenaviruses share a highly conserved epitope in the fusion domain of the glycoprotein 2, which is recognized by Lassa virus-specific human CD4+ T-cell clones

Virology

Volumn 321, Issue 1, 2004, Pages 134-143

  Ter Meulen, Jan ^a,f   Badusche, Marlis ^b   Satoguina, Judith ^b   Strecker, Thomas ^a   Lenz, Oliver ^a   Loeliger, Cornelius ^c   Sakho, Mohamed ^d   Koulemou, Kekoura ^d   Koivogui, Lamine ^d   Hoerauf, Achim ^b,e  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d CHU Donka   (Guinea)

^e UNIVERSITY OF BONN   (Germany)

^f CRUCELL HOLLAND BV   (Netherlands)

Author keywords

CD4 T cells; Epitopes; Glycoprotein 2; Lassa virus

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; EPITOPE; GAMMA INTERFERON; GLYCOPROTEIN IIB; VIRUS GLYCOPROTEIN;

AMINO TERMINAL SEQUENCE; ANTIGEN RECOGNITION; ARTICLE; CLADISTICS; CONTROLLED STUDY; GENETIC CONSERVATION; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; LASSA VIRUS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RESTRICTION FRAGMENT; SPECIES COMPARISON; VIRUS GENOME;

AMINO ACID SEQUENCE; ARENAVIRUS; BLOOD DONORS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CLONE CELLS; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; FEMALE; GLYCOPROTEINS; HUMANS; LASSA VIRUS; MALE; MOLECULAR SEQUENCE DATA; PEPTIDES; SEQUENCE ALIGNMENT; SPECIES SPECIFICITY; VIRAL ENVELOPE PROTEINS;

ANIMALIA; ARENAVIRUS; LASSA VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NEW WORLD ARENAVIRUSES;

EID: 12144290623     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2003.12.013     Document Type: Article

References (37)

1. Bowen M.D., Rollin P.E., Ksiazek T.G., Hustad H.L., Bausch D.G., Demby A.H., Bajani M.D., Peters C.J., Nichol S.T. Genetic diversity among Lassa virus strains. J. Virol. 74:2000;6992-7004.
2. Charrel R.N., Feldmann H., Fulhorst F.C., Khelifa R., de Chesse R., de Lamballerie X. Phylogeny of New World arenaviruses based on the complete coding sequences of the small genomic segment identified an evolutionary lineage produced by intrasegmental recombination. Biochem. Biophys. Res. Commun. 296:2002;1118-1124.
3. Ciatto C., Tissot A.C., Tschopp M., Capitani G., Pecorari F., Plueckthun A., Gruetter M.G. Zooming in on the hydrophobic ridge of H-2Db: implications for the conformational variability of bound peptides. J. Mol. Biol. 312:2001;1059-1071.
4. de Jong A., van der Burg S.H., Kwappenberg K.M., van der Hulst J.M., Franken K.L., Geluk A., van Meijgaarden K.E., Drijfhout J.W., Kenter G., Vermeij P., Melief C.J., Offringa R. Frequent detection of human papillomavirus 16 E2-specific T-helper immunity in healthy subjects. Cancer Res. 62:2002;472-479.
5. Diepolder H.M., Gerlach J.-T., Zachoval R., Hoffmann R.M., Ung M.-C., Wierenga E.A., Scholz S., Santantonio T., Houghton M., Southwood S., Sette A., Pape G. Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute Hepatitis C virus infection. J. Virol. 71:1997;6011-6019.
6. Djavani M., Lin C., Lukashevich I.S., Rodas J., Rai S.K., Salvat M.S. Mucosal immunization with Salmonella typhimurium expressing Lassa virus nucleocapsid protein cross-protects mice from lethal challenge with lymphocytic choriomeningitis virus. J. Hum. Virol. 4:2001;103-108.
7. Erlich H., Bugawan T., Begovich A.B., Scharf S., Griffith R., Saiki R., Higuchi R., Walsh P.S. HLA-DR, DQ and DP typing using PCR amplification and immobilized probes. Eur. J. Immunogenet. 18:1991;33-55.
8. Fisher-Hoch S., Hutwanger L., Brown B., McCormick J.P. Effective vaccine for Lassa fever. J. Virol. 74:2000;6777-6783.
9. Glushakova S.E., Lukashevich I.S., Baratova A. Prediction of arenavirus fusion peptides on the basis of computer analysis of envelope protein sequences. FEBS. 269:1990;145-147.
10. Jahrling P.B., Peters C.J. Serology and virulence diversity among Old-World arenaviruses, and the relevance to vaccine development. Med. Microbiol. Immunol. 175:1986;165-167.
11. Jahrling P.B., Frame J.D., Rhoderick J.B., Monson M.H. Endemic Lassa fever in Liberia: IV. Selection of optimally effective plasma for treatment by passive immunization. Trans. R. Soc. Trop. Med. Hyg. 79:1985;380-384.
12. Johnson K.M., McCormick J.B., Webb P.A., Smith E.S., Elliot L.H., King I.J. Clinical virology of Lassa fever in hospitalized patients. J. Infect. Dis. 155:1987;456-463.
13. Kiley M.P., Lange J.V., Johnson K.M. Protection of rhesus monkeys from Lassa virus by immunization with a closely related arenavirus. Lancet. 2:1979;738.
14. Klotz L.D., Khan A.S., Lillibridge S.R., Ostroff S.M., Hughe J.M. Public health assessment of potential biological terrorism agents. Emerg. Infect. Dis. 8:2002;225-230.
15. Kurane I., Zeng L., Brinton M.A., Ennis F.A. Definition of an epitope on NS3 recognized by human CD4+ cytotoxic T lymphocyte clones cross-reactive for Dengue virus types 2, 3, and 4. Virology. 240:1998;169-174.
16. Lamonaca V., Missale G., Urbani S., Pilli M., Boni C., Mori C., Sette A., Massari M., Southwood S., Bertoni R., Valli A., Fiaccadori F., Ferrari C. Conserved Hepatitis C virus sequences are highly immunogenic for CD4+ cells: implications for vaccine development. Hepatology. 30:1999;1088-1098.
17. Lampson L., Levy R. Two populations of Ia-like antigens on a human B cell line. J. Immunol. 125:1980;293-299.
18. + T-cell clone specific for an envelope glycoprotein of Lassa virus. J. Virol. 67:1993;3497-3506.
19. Lenz O., ter Meulen J., Klenk H.-D., Seidah N.G., Garten W. The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P. Proc. Natl. Acad. Sci. U.S.A. 98:2001;12701-12705.
20. Marttila J., Hyoty H., Vilja P., Harkonen T., Alho A., Roivainen M., Hyypia T., Ilonen J. T cell epitopes in coxsackievirus B4 structural proteins concentrate in regions conserved between enteroviruses. Virology. 293:2002;217-224.
21. McCormick J.B., Webb P.A., Krebs J.W., Johnson K.M., Smith E.S. A prospective study of the epidemiology and ecology of Lassa fever. J. Infect. Dis. 155:1987;437-444.
22. Olive M., Eisenlohr L., Flomenberg N., Hsu S., Flomenberg P. The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope. Hum. Gene Ther. 13:2002;1167-1178.
23. Pawelec G., Ziegler A., Wernet P. Dissection of human allostimulatory determinants with cloned T cells: stimulation inhibition by monoclonal antibodies TU 22, 34, 36, 37, 39, 43 and 58 against distinct human MHC class II molecules. Hum. Immunol. 12:1985;165.
24. Pushko P., Geisbert J., Parker M., Jahrling P., Smith J. Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses. J. Virol. 75:2001;11677-11685.
25. Ruo S.L., Mitchell S.W., Kiley M.P., Roumillat L.F., Fisher-Hoch S., McCormick J.B. Antigenic relatedness between arenaviruses defined at the epitope level by monoclonal antibodies. J. Gen. Virol. 72:1991;549-555.
26. Sanchez-Mazas A. African diversity from the HLA point of view: influence of genetic drift, geography, linguistics, and natural selection. Hum. Immunol. 62:2001;937-948.
27. Singh H., Raghava G.P.S. ProPred: prediction of HLA-DR binding sites. Bioinformatics. 17:2001;1236-1237.
28. Sturniolo T., Bono E., Ding J., Raddrizzani L., Tuercei O., Sahin U., Braxenthaler M., Gallazi F., Frotti M.P., Sinigaglia F., Hammer J. Generation of tissue-specific and promiscuous HLA ligand database using DNA microarrays and virtual HLA class II matrices. Nat. Biotechnol. 17:1999;555-561.
29. ter Meulen J., Koulemou K., Wittekindt T., Windisch K., Strigl S., Conde S., Schmitz H. Detection of Lassa virus antinucleoprotein immunoglobulin G (IgG) and IgM antibodies with a simple recombinant immunoblot assay for field use. J. Clin. Microbiol. 36:1998;3143-3148.
30. ter Meulen J., Badusche M., Kuhnt K., Doetze A., Satoguina J., Marti T., Loeliger C., Koulemou K., Koivogui L., Schmitz H., Fleischer B., Hoerauf A. Characterization of human CD4+ T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein. J. Virol. 74:2000;2186-2192.
31. The QIAexpressionist, 1992. Quiagen, Hilden, Germany.
32. Tomori O., Johnson K.M., Kiley M.P., Elliot L.H. Standardization of a plaque assay for Lassa virus. J. Med. Virol. 22:1987;77-89.
33. van der Burg S.H., Kwappenberg K.M.C., Geluk A., Van der Kruk M., Potesilli O., Hovenkamp E., Franken K.L.M.C., van Meijgaarden K.E., Drijfhout J.-W., Ottenhoff T.H.M., Melief C.J.M., Offringa R. Identification of a coserved universal Th epitope in HIV-1 reverse transcriptase that is processed and presented to HIV-specific CD4+ T cells by at least four unrelated HLA-DR molecules. J. Immunol. 162:1999;152-160.
34. Wang H., Eckels D.D. Mutations in immunodominant T cell epitopes derived from the nonstructural 3 protein of Hepatitis C virus have the potential for generating escape variants that may have important consequences for T cell recognition. J. Immunol. 162:1999;4177-4183.
35. Weber E.L., Buchmeier M.J. Fine mapping of a peptide sequence containing an antigenic site conserved among arenaviruses. Virology. 164:1988;30-38.
36. Wilson C.C., Palmer B., Southwood S., Sidney J., Higashimoto Y., Appella E., Chesnut R., Sette A., Livingstone B.D. Identification and antigenicity of broadly cross-reactive and conserved Human Immunodeficiency Virus type 1-derived helper T-lymphocyte epitopes. J. Virol. 75:2001;4195-4207.
37. Zachary A.A., Bias W.B., Johnson A., Rose S.M., Leffell M.S. Antigen, allele, and haplotype frequencies report of the ASHI minority antigens workshops: part 1, African-Americans. Hum. Immunol. 62(10):2001;1127-1136.